Free Trial
NASDAQ:ATHX

Athersys (ATHX) Stock Price, News & Analysis

Athersys logo

About Athersys Stock (NASDAQ:ATHX)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6,322 shs
Average Volume
1.77 million shs
Market Capitalization
$833 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATHX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athersys and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATHX Stock News Headlines

Athersys, Inc. (ATHXQ)
The best AI stock you aren’t watching (but Elon is)
Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public could quietly supply the tech that makes Elon's AI machines think, see, and move like humans. But it could be your best shot to ride this wave from the inside out.tc pixel
Toughbuilt Industries Inc (TBLT)
Athersys Inc ATHXQ
Athersys to Sell Most Assets to Healios
See More Headlines

ATHX Stock Analysis - Frequently Asked Questions

Athersys, Inc. (NASDAQ:ATHX) announced its earnings results on Monday, November, 15th. The biopharmaceutical company reported ($1.75) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.00) by $0.25. The biopharmaceutical company had revenue of $4.79 million for the quarter.

Athersys shares reverse split on Monday, August 29th 2022.The 1-25 reverse split was announced on Monday, August 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of ATHX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athersys investors own include Bank of America (BAC), Predictive Oncology (POAI), Ford Motor (F), Agenus (AGEN), JPMorgan Chase & Co. (JPM), Wells Fargo & Company (WFC) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
11/15/2021
Today
10/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATHX
CIK
1368148
Employees
24
Year Founded
1995

Profitability

EPS (Trailing Twelve Months)
($2.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.53 million
Net Margins
N/A
Pretax Margin
-46,304.93%
Return on Equity
N/A
Return on Assets
-223.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.06
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$146 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.33) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
61,719,000
Free Float
61,700,000
Market Cap
$833 thousand
Optionable
No Data
Beta
-0.90

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ATHX) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners